Donafenib

5 registered clinical trials studyying Donafenib — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC NCT06609876	Sun Yat-sen University	N/A
Unknown	Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery NCT04962958	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2
Unknown	A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC NCT05205629	Shanghai Zhongshan Hospital	—
Unknown	A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical NCT05200221	Shanghai Zhongshan Hospital	—
Completed	A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC NCT05262959	Shanghai Zhongshan Hospital	Phase 2